Login / Signup

The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.

Colin D GodwinOlivia M BatesEliotte E GarlingMary E BeddoeGeorge S LaszloRoland Bruno Walter
Published in: British journal of haematology (2020)
Keyphrases
  • chronic lymphocytic leukemia